New therapy gives prostate cancer patients new hope!

For many men,

prostate cancer is a serious threat and, with 27 percent, is the most common malignant illness in Austria. In view of the steadily increasing diagnoses, most recently over 6,000 new cases in 2019, the need for optimal treatment methods is becoming increasingly urgent. A promising nuclear medical therapy was introduced in the Klagenfurt Clinic, which is specially intended for patients in which other treatments have failed. As kaernten.Af.at reports, enable PET-CT examinations, determine whether the tumor has the necessary prostate-specific membrane-antigen (PSMA), which is a prerequisite for treatment. The therapy aims to target tumor cells and stop their spread.

The treatment is mainly on the scene when prostate cancer progresses despite hormone and chemotherapy. Thanks to the new form of therapy, which is carried out every week in four patients in the Klagenfurt Clinic, patients such as Ronald Herrmann, who has lived with the illness for ten years, can draw hope again. Herrmann, who was considered to be exploited, explained that the therapy supported him so well that he can look optimistically into the future. "I thought that I will not be entirely experienced for the coming year," said Herrmann. This individual therapy option could enable the majority of the patients to increase their quality of life and time, as Christian Uprimny, head of nuclear medicine at the Klagenfurt Clinic, emphasized.

Innovative therapy approaches in the prostate cancer center Wels

In addition to nuclear medical therapy, the Wels prostate cancer center offers tailor -made treatment options that are based on the latest scientific knowledge. As Klinikum-wegr.at , minimally invasive interventions with the latest robot surgery also play a crucial role. Prim. Dr. Clemens G. Wiesinger explains that the state -of -the -art robot instruments allow to carry out precise operations while healthy tissue is spared. This leads to less blood loss and faster recovery times for the patients.